Mirae Asset Global Investments
CBAY

Mirae Asset Global Investments’s Cymabay Therapeutics CBAY Stock Holding History

Mirae Asset Global Investments’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-48,669
Closed -$1.15M – 2693
2023
Q4 		$1.15M Buy
48,669
+525
+1% +$9.35K ﹤0.01% 1546
2023
Q3 		$718K Buy
48,144
+101
+0.2% +$1.34K ﹤0.01% 1701
2023
Q2 		$526K Buy
+48,043
New +$447K ﹤0.01% 1925

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global Investments's CBAY Position: Q1 2024 in Review

Mirae Asset Global Investments sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 48,669 shares — an estimated $1.15M sold.

Mirae Asset Global Investments first reported a position in CBAY in Q2 2023 and held it in 3 quarters. The position peaked at $1.15M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Mirae Asset Global Investments reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 48,669 Cymabay Therapeutics shares in Q1 2024, an estimated $1.15M.
  • Mirae Asset Global Investments first reported a position in Cymabay Therapeutics in Q2 2023 and held it in 3 quarters.
  • Mirae Asset Global Investments's Cymabay Therapeutics position peaked at $1.15M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Mirae Asset Global Investments's 13F filing for Q1 2024, filed 1 May 2024.